Edoardo Marrani

Dr. Edoardo Marrani

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GFGiovanna Ferrara
Giovanna Ferrara
MPMaria Grazia Petrillo
Maria Grazia Petrillo
TGTeresa Giani
Teresa Giani
EMEdoardo Marrani
Edoardo Marrani
CFCesare Filippeschi
Cesare Filippeschi
RCRolando Cimaz
Rolando Cimaz
Corticosteroids are the mainstay of therapy for many pediatric disorders and sometimes are life-saving. Both endogenous and synthetic derivatives diffuse across the cell membrane and, by binding to their cognate glucocorticoid receptor, modulate a variety of physiological functions, such as glucose metabolism, immune homeostasis, organ development, and the endocrine system. However, despite their proved and known efficacy, corticosteroids show a lot of side effects, among which growth retardation is of particular concern and specific for pediatric age. The aim of this review is to discuss the mechanism of action of corticosteroids, and how their genomic effects have both beneficial and adverse consequences. We will focus on the use of corticosteroids in different pediatric subspecialties and most common diseases, analyzing the most recent evidence.

30 June 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
FCFrancesco Caso
Francesco Caso
LCLuisa Costa
Luisa Costa
Donato RiganteDonato Rigante
Donato Rigante
OLOrso Maria Lucherini
Orso Maria Lucherini
PCPaolo Caso
Paolo Caso
LCLuca Cantarini
Luca Cantarini
Behçet’s disease (BD) is universally recognized as a multisystemic inflammatory disease of unknown etiology with chronic course and unpredictable exacerbations: its clinical spectrum varies from pure vasculitic manifestations with thrombotic complications to protean inflammatory involvement of multiple organs and tissues. Treatment has been revolutionized by the progressed knowledge in the pathogenetic mechanisms of BD, involving dysfunction and oversecretion of multiple proinflammatory molecules, chiefly tumor necrosis factor- (TNF-)α, interleukin- (IL-) 1β, and IL-6. However, although biological treatment with anti-TNF-αagents has been largely demonstrated to be effective in BD, not all patients are definite responders, and this beneficial response might drop off over time. Therefore, additional therapies for a subset of refractory patients with BD are inevitably needed. Different agents targeting various cytokines and their receptors or cell surface molecules have been studied: the IL-1 receptor has been targeted by anakinra, the IL-1 by canakinumab and gevokizumab, the IL-6 receptor by tocilizumab, the IL12/23 receptor by ustekinumab, and the B-lymphocyte antigen CD-20 by rituximab. The aim of this review is to summarize all current experiences and the most recent evidence regarding these novel approaches with biological drugs other than TNF-αblockers in BD, providing a valuable addition to the actually available therapeutic armamentarium.

30 March 2021 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
IFIvan Foeldvari
Ivan Foeldvari
JKJens Klotsche
Jens Klotsche
OKOzgur Kasapcopur
Ozgur Kasapcopur
AAAmra Adrovic
Amra Adrovic
MTMaria Teresa Terreri
Maria Teresa Terreri
KTKathryn Seraphin Torok
Kathryn Seraphin Torok

17 July 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
CRChiara Rubino
Chiara Rubino
CMCostanza Monacelli
Costanza Monacelli
EMEdoardo Marrani
Edoardo Marrani
MPMonica Paci
Monica Paci
GIGiuseppe Indolfi
Giuseppe Indolfi
STSandra Trapani
Sandra Trapani

27 August 2015 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
EMEdoardo Marrani
Edoardo Marrani
VPValeria Paganelli
Valeria Paganelli
CLCinzia de Libero
Cinzia de Libero
RCRolando Cimaz
Rolando Cimaz
GSGabriele Simonini
Gabriele Simonini

3 November 2020 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
IFIvan Foeldvari
Ivan Foeldvari
JKJens Klotsche
Jens Klotsche
BHBernd Hinrichs
Bernd Hinrichs
NHNicola Helmus
Nicola Helmus
OKOzgur Kasapcopur
Ozgur Kasapcopur
KTKathryn Seraphin Torok
Kathryn Seraphin Torok